DE:2Q5 / Lunai Bioworks Inc. - Net Long/Short Value

Lunai Bioworks Inc.
DE ˙ DB ˙ US29350E1047
0,10 € 0,00 (0,00%)
2025-11-28
DEL PRIS
DE:2Q5 / Lunai Bioworks Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Vanguard Group Inc
Northern Trust Corp
XTX Topco Ltd
Goldman Sachs Group Inc
Jpmorgan Chase & Co
UBS Group AG
State Street Corp
Jump Financial, LLC
Tower Research Capital LLC (TRC)
Virtu Financial LLC
Vanguard Global Advisers, LLC
NINE MASTS CAPITAL Ltd
Scientech Research LLC
Geode Capital Management, Llc
BlackRock, Inc.
Vanguard Fiduciary Trust Co
Citigroup Inc
Commonwealth Equity Services, Llc
Group One Trading, L.p.
Vanguard Capital Management Llc
International Assets Investment Management, Llc
Optiver Holding B.V.
Bnp Paribas Arbitrage, Sa
Morgan Stanley
SBI Securities Co., Ltd.
Two Sigma Securities, Llc
Simplex Trading, Llc
Deutsche Bank Ag\
Royal Bank Of Canada
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:LNAI 2,87 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista